Advertisement

Topics

BioPath Holdings Inc BPTH Medical Equipment Deals and Alliances Profile [Report Updated: 17102017] Prices from USD $250

18:08 EDT 3 Nov 2017 | BioPortfolio Reports

Summary


BioPath Holdings Inc BioPath is a clinical stage biotechnology company which develops targeted therapies for acute myeloid leukemia AML, chronic myeloid leukemia CML and other challenging cancers. The company's products pipeline includes prexigebersen Liposomal Grb2 Antisense and BP1002 Liposomal Bcl2. Its prexigebersen Liposomal Grb2 Antisense, is developed for the treatment of Acute Myeloid Leukemia AML and solid tumors. BioPath's BP1002 Liposomal Bcl2 is used for the treatment of lymphoma, leukemia, colon, prostate and breast cancers. The company's proprietary liposomal delivery and antisense technology platform DNAbilize, is used to systemically distribute nucleic acid drugs throughout the human body with a simple intravenous transfusion. BioPath is headquartered in Bellaire, Texas, the US.


BioPath Holdings Inc BPTH Medical Equipment Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions MAs, partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, subsector and regions.


GlobalData derived the data presented in this report from proprietary inhouse Medical eTrack deals database, and primary and secondary research.


Scope


Financial Deals Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Subsector Chart and table showing information on the number of deals and value reported by the company, by subsector.

Major Deals Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's major public companies key financial metrics and ratios.

Business Description A brief description of the company's operations.

Key Employees A list of the key executives of the company.

Important Locations and Subsidiaries A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors A list of the key competitors of the company.

Key Recent Developments A brief on recent news about the company.


Reasons to Buy


Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.


Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.


Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.


Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.


Stay uptodate on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.


Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.


Note*: Some sections may be missing if data is unavailable for the company.

Original Article: BioPath Holdings Inc BPTH Medical Equipment Deals and Alliances Profile [Report Updated: 17102017] Prices from USD $250

NEXT ARTICLE

More From BioPortfolio on "BioPath Holdings Inc BPTH Medical Equipment Deals and Alliances Profile [Report Updated: 17102017] Prices from USD $250"

Quick Search
Advertisement
 

Relevant Topics

Bioscience
Bioscience - any of the sciences that deal with living organisms.  The study of the nature, behavior, and uses of living organisms as applied to biology. Any of the branches of natural science dealing with living things, such as their structure, b...

Leukemia
Leukemia is a type of cancer of the blood or bone marrow characterized by an abnormal increase of immature white blood cells called "blasts". Leukemia is a broad term covering a spectrum of diseases. In turn, it is part of the even broader grou...